thrombogenic

throm·bo·gen·ic

(throm'bō-jen'ik),
1. Relating to thrombogen.
2. Causing thrombosis or coagulation of the blood.

thrombogenic

(thrŏm′bə-jĕn′ĭk)
adj.
Causing or resulting in thrombosis or coagulation of the blood.

thrombogenic

[-jen′ik]
Etymology: Gk, thrombos + genein, to produce
pertaining to a thrombus or a factor that causes a thrombus.

throm·bo·gen·ic

(throm'bō-jen'ik)
1. Relating to thrombogen.
2. Causing thrombosis or coagulation of the blood.
References in periodicals archive ?
We showed that visceral fat accumulation causes abnormalities in adipocytokine secretion, such as hypersecretion of plasminogen activator inhibitor 1, which is related to thrombogenic vascular diseases.
Thrombogenic mechanisms of anti phospholipid antibodies [Review].
Reaming and pressurising of the femoral canal releases emboli into the circulation (9), which include substances that are vasoactive, inflammatory and thrombogenic (10,11).
Anticardiolipin antibodies and recurreent coronary events: a prospective study of 1150 patients: Thrombogenic Factors and Recurrent Coronary Events Investigators.
The researchers noted a number of factors that may contribute to flight-associated edema and release of thrombogenic factors, including compression of the popliteal vein on the edge of the seat, immobility, decreased fluid intake, water loss in the dry atmosphere, decreased air pressure, and relative hypoxia.
When AT levels decrease, additional thrombosis can occur as a result of decreased control of thrombogenic activity.
Because the coils are thrombogenic, one of the major risks is stroke.
Their material properties provide benefits such as reduced thrombogenic potential, minimal inflammatory response and enhanced growth of certain cells on the surface of the device.
To evaluate the risk of coronary disease, atherogenic and thrombogenic indexes were calculated as suggested by Ulbricht and Southgate (1991).
The marketing approvals are based on changes Octapharma has made in the octagam 5% and octagam 10% manufacturing process and the company's decision to implement a quality control test on every batch of product that is released to the marketplace for the absence of thrombogenic potential.
Thus, "RBC-derived microparticles" in WB might be thrombogenic, depending on manufacturing and storage conditions.